鲑鱼降钙素对血液透析肾性骨病的治疗作用观察被引量：1

导出

摘要目的观察鲑鱼降钙素皮下注射对血液透析患者肾性骨病的疗效。方法选择维持性血液透析患者28例,予皮下注射鲑鱼降钙素注射液,开始时每天1次,每次50 U,2周以后,每周3次,每次用量为50 U。均为透析后使用,3个月为1疗程,同时低嘌呤饮食,停服止痛剂。结果鲑鱼降钙素能有效降低血钙、血磷、甲状旁腺激素(PTH),与治疗前比较有显著差异。治疗后患者骨痛、肌无力、皮肤瘙痒消失。结论鲑鱼降钙素治疗肾性骨病疗效显著,使用方便,值得推广应用。

作者王银娥

机构地区常州市第七人民医院

出处《基层医学论坛》 2012年第31期4137-4138,共2页 The Medical Forum

关键词血液透析肾性骨病继发性甲状旁腺功能亢进鲑鱼降钙素

分类号 R692.5 [医药卫生—泌尿科学]

引文网络
相关文献

参考文献4

1李荣山,甄国华,程丽娟,邵珊,高仁义,李建萍,李元红,成秀芬,张渝,刘静.血液灌流对继发性甲状旁腺功能亢进的影响[J].中国血液净化,2005,4(5):277-278. 被引量：25
2于续芳,黄占东.鲑鱼降钙素治疗血液透析肾性骨病患者疗效分析[J].基层医学论坛,2011,15(1):37-38. 被引量：13
3Chesnut CH,Silveman S,Andviano k,et al A vandomized tial of nasal spay salmon calcitonin in postmenopausal women with established osteporosis: the prevnt recurrence of osteoporasis farcture study.PROOF study Group [J].Am J Med,2000,109(6) :267-276.
4张东亮,尹道馨,郭王,林雅慧,刘文虎.鲑鱼降钙素治疗维持性血液透析骨量减少的患者[J].中华肾脏病杂志,2008,24(10):690-694. 被引量：5

二级参考文献14

1李荣山,甄国华,程丽娟,邵珊,高仁义,李建萍,李元红,成秀芬,张渝,刘静.血液灌流对继发性甲状旁腺功能亢进的影响[J].中国血液净化,2005,4(5):277-278. 被引量：25
2Chesnut CH 3rd, Silverman S, Andriano K, et al. A randomizcd trial of nasal spray sahnon calcitonin in postmenopausal women with established ostcoporosis: the prevent recurrence of osteoporosis farcture study. PROOF Study Group. Am J Med, 2000, 109: 267-276.
3Kurnatowska I, Zygmunt A, Fijalkowska-Morawska J, el al. Hormonal activity of the hypophysial-gonadal axis versus tile mineral bone densily and speeifie markers of bone trunover ill haemodialysis population. Pol Merkur Lekarski, 2006, 20: 408-412.
4Palmer S, McGregor DO, Strippoli GF. Interventions for preventing bone disease in kidney transplant recipients. Cochrane Database Syst Rev, 2005, (2): CD005015.
5Matuszkiewicz-Rowinska J, Niemczyk S, Przedlacki J, et al. Effect of salmon calcitonin on hone mineral density and calcium-phosphate metabolism in chronic hemodialysis patients with secondary hyperparathyroidism. PoX Arch Med Wewn, 2004, 112: 797-803.
6Morena M, Terrier N, Jaussent 1, et al. Plasma osteoprotegerin is associated with mortality in hemodialysis patients. J Am Soc Nephrol, 2006, 17: 262-270.
7Avbersck-Luznik 1, Balon BP, Rus 1, et al. Increased bone resorption in HD patients: is it caused by elevated RANKL synthesis? Nephrol Dial Transplant, 2005, 20: 566-570.
8Spicehowiez U, Kokot F, Wieeek A. Markers of calciumphosphate metabolism and bones alterations in long term kidney transplant patients. Przegl Lek, 2003, 60: 690-694.
9王海燕王梅.慢性肾脏病及透析的临床实践指南Ⅱ[M].北京:人民卫生出版社,2005,6.133-166.
10林雅慧,姜国红,张东亮,刘文虎.96例维持性血液透析患者骨质疏松症患病情况分析[J].中国血液净化,2007,6(9):478-480. 被引量：11